Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Deep sequencing of the off-target site identified by iGUIDE in different infusion products

PROVIDER: PRJNA772893 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR16493765_1.fastq.gz	Fastqsanger.gz
	SRR16493765_2.fastq.gz	Fastqsanger.gz
	SRR16493766_1.fastq.gz	Fastqsanger.gz
	SRR16493766_2.fastq.gz	Fastqsanger.gz
	SRR16493767_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 20

Similar Datasets

Project description:Deep sequencing of top 24 off-target sites identified by iGUIDE

| PRJNA772887 | ENA

Project description:Deep sequencing of top 24 off-target sites identified by iGUIDE (wrongly submitted)

| PRJNA773518 | ENA

Deep sequencing of HetR-bound DNA reveals novel HetR targets in Anabaena sp. strain PCC 7120

2013-10-31 | GSE51886 | GEO

Single-cell transcriptomics of chimeric antigen receptor T-cell infusion products

Project description:Single-cell RNA sequencing of residual cells from 24 CAR T-cell infusion products.

2020-07-28 | GSE151511 | GEO

Deep sequencing of HetR-bound DNA reveals novel HetR targets in Anabaena sp. strain PCC 7120

Project description:We employed chromatin pull-down and deep sequencing to globally identify HetR DNA targets in vivo at 6 hours after fixed-nitrogen deprivation. We identified novel DNA binding targets of tagged HetR-6xHis and defined a consensus HetR binding site from these HetR target sequences. Chromatin pull down of hetR mutant strain UHM103 carrying pAM4375, which expresses HetR-6xHis, and a wild-type control. One dataset was collected.

2013-10-31 | E-GEOD-51886 | biostudies-arrayexpress

CapID sequencing of 40 chimeric antigen receptor T-cell infusion products were reported

Project description:Hybrid capture single-cell RNA sequencing of residual cells from 24 CAR T-cell infusion products.

2020-07-28 | GSE150992 | GEO

Differential dynamics of response at single cell resolution following CAR-T therapy in refractory B-cell lymphoma

Project description:Single-cell RNA sequencing of PBMCs and infusion products from 32 patients treated with CD19 CAR-T therapy

2022-07-13 | GSE197268 | GEO

Project description:Deep amplicon sequencing of the doublesex gene drive target site

| PRJNA476358 | ENA

Genome-wide analysis reveals characteristics of off-target sites bound by the Cas9 endonuclease

Project description:RNA-guided genome editing with the CRISPR-Cas9 system has great potential for basic and clinical research, but the determinants of targeting specificity and the extent of off-target cleavage remain insufficiently understood. Using chromatin immunoprecipitation and high-throughput sequencing (ChIP-seq), we mapped genome-wide binding sites of catalytically inactive Cas9 (dCas9) in HEK293T cells, in combination with 12 different single guide RNAs (sgRNAs). The number of off-target sites bound by dCas9 varied from ~10 to >1,000 depending on the sgRNA. Analysis of off-target binding sites showed the importance of the PAM-proximal region of the sgRNA guiding sequence and that dCas9 binding sites are enriched in open chromatin regions. When targeted with catalytically active Cas9, some off-target binding sites had indels above background levels in a region around the ChIP-seq peak, but generally at lower rates than the on-target sites. Our results elucidate major determinants of Cas9 targeting, and we show that ChIP-seq allows unbiased detection of Cas9 binding sites genome-wide 1.sgRNA1-6 binding sites were identified with ChipSeq by using HA antibody (there are 2 replicates for sgRNA1-3, one sample for sgRNA4-6,one control without sgRNA) 2.PCR products which amplifies " off-target genomic sites" were deep sequenced in the presence of WT Cas9+sgRNA or WT Cas9 alone( unique adaptor was used for each sgRNA and mixed for multiplex run)

2014-05-18 | E-GEOD-55887 | biostudies-arrayexpress

397d0ebd-2c5a-48cf-93c1-4c74455ba9f8 - samples

Project description:Single cell full transcriptome sequencing of CD19 CAR T-cell infusion products used for standard of care treatment for relapsed/refractory large B-cell lymphoma.

| EGAD00001006325 | EGA

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data